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Background
Lamotrigine is a commonly used in psychiatric patients.
The aims of this study were to determine the possible
associations of lamotrigine-induced hypersensitivity
syndrome with the HLA-B alleles in Thai patients.
HLA-B*58:01 allele was also observed in Han Chinese
patients with epilepsy and lamotrigine-induced SCARs
(severe cutaneous adverse drug reactions).
Method
A total of 133 patients, including 11 patients with
lamotrigine-induced hypersensitivity syndrome (MPE;
maculo-papular exanthema, SJS; Stevens-Johnson
syndrome and TEN; toxic epidermal necrolysis),
9 lamotrigine-tolerant controls and 113 healthy controls
were included in this study. HLA-B genotyping was
performed. This case-control study was approved by the
Ethics Committee of Ramathibodi Hospital.
Results
HLA-B*15:02 allele was present in 27.3% (3/11) of Thai
patients with lamotrigine-induced hypersensitivity syn-
drome but in only 11.1% (1/9) of lamotrigine-tolerant
controls and 13.2% of 113 healthy controls (P-value
<0.05). Other HLA-B allele, including HLA-B*58:01 was
observed in a case group.
Conclusion
Our results support the hypothesis that HLA-B*15:02
contribute to the genetic susceptibility to lamotrigine-
induced hypersensitivity syndrome and may be valuable
as potential biomarkers for prediction lamotrigine-
induced hypersensitivity syndrome in Thai population.
A major limitation of this study was the size of the sample
available for the analysis. Confirmation of these results in
a larger, independent sample is needed.
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